Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abciximab in ACS patients undergoing PCI (ISAR-REACT-2)
NCT00133003Phase 4Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Mar 2003
- Primary completion
- Jan 2006
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 4 trial of abciximab in acute coronary syndrome (ACS), sponsored by Deutsches Herzzentrum München. Started Mar 2003; status: completed.
02
Drugs
abciximab
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00133003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133003.